The worrying explosion of cancer costs in France

two-tier medicine“.” data-reactid = “18”> According to a study, between 2004 and 2017, the cost to treat diseases rose from 20.3 to 28 billion euros. The reason: soaring drug prices threaten the risk of “two-tier medicine“.

The price of drugs is soaring. The risk of two-tier medicine is real“, details the author of popular bestsellers for popularization. According to a study carried out by the cabinet Asterès, the cost of cancer has indeed gone from 20.3 billion euros in 2004 to 28 billion euros in 2017. A trajectory “not surprising“according to the economist at the head of the study Pierre Bentata who explains that”the population is aging and the health system, which treats us better, is in a way victim of its success“.” data-reactid = “19”> The inventor of the cancer plan in 2003 sounded the alarm. In the “hooly-news.com”, the famous oncologist David Khayat, alerts the authorities to the exploding costs of cancer in France. “The price of drugs is soaring. The risk of two-tier medicine is real“, details the author of popular bestsellers for popularization. According to a study carried out by the cabinet Asterès, the cost of cancer has indeed gone from 20.3 billion euros in 2004 to 28 billion euros in 2017. A trajectory “not surprising“according to the economist at the head of the study Pierre Bentata who explains that”the population is aging and the health system, which treats us better, is in a way victim of its success“.

the appearance of more effective treatments, but also more expensive and by a larger number of patients treated“, analysis in the JDD Nicolas Bouzou, president of the cabinet Asterès.” data-reactid = “20”> Spending on healthcare, particularly hospitalization and medication, increased the most between 2004 and 2017. Three years ago, it reached 16.5 billion euros, an increase of 50% compared to 2004. An increase which is explained by “the appearance of more effective treatments, but also more expensive and by a larger number of patients treated“, analysis in the JDD Nicolas Bouzou, president of the cabinet Asterès.

To calculate the direct cost of cancer, estimated at 18.3 billion euros, the study took into account the prevention policy – 139 million euros to combat the consumption of tobacco or alcohol – the expenses for screening – 172 million euros for mammograms or colon cancer screening kits – and public research, whose budget is 694 million euros.

We used a key notion in health economics: that of lost years. This may seem shocking to the general public, but it is a very enlightening indicator“, details Pierre Bentata.” data-reactid = “22”> To quantify the indirect cost, she measured the economic losses linked to early deaths. “We used a key notion in health economics: that of lost years. This may seem shocking to the general public, but it is a very enlightening indicator“, details Pierre Bentata.

The 2.3 million (…)

Click here to see more“data-reactid =” 24 “>Click here to see more